by Sermonix Pharmaceuticals | Sep 23, 2019 | News
Biopharmaceutical company is partnering with Sysmex Inostics to identify appropriate study candidates with the OncoBEAM™ ESR1 liquid biopsy test COLUMBUS, Ohio, Sept. 23, 2019 (GLOBE NEWSWIRE) — Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company...
by Sermonix Pharmaceuticals | Sep 23, 2019 | News
Sept. 26 presentation in Chicago demonstrates the need for improvement in practitioners’ understanding of patients’ intimacy concerns COLUMBUS, Ohio, Sept. 25, 2019 (GLOBE NEWSWIRE) — Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on...
Recent Comments